Summary: African health technology company Helium Health is acquiring Meddy, Hexarad is creating a share program to attract radiologists and more briefings

Helium Health acquires doctor booking platform Meddy Inc.

African health technology provider Helium Health has announced the acquisition of doctor booking platform Meddy Inc., which operates in Qatar and the United Arab Emirates.

Helium, which has a presence in Nigeria, Ghana, Liberia, Senegal, Kenya and Uganda, plans to deploy its electronic medical record (EMR) technology and healthcare financial solutions across the GCC market.

Adegoke Olubusi, CEO of Helium, said, “There is a great market opportunity in Qatar, the United Arab Emirates and KSA to work with care providers to improve patient interaction, make health data more interoperable and improve sales cycle management.”

Teleradiology company Hexarad creates share program

Radiologists who work for the British startup Hexarad can now purchase shares in the company in addition to their telecommunications fees.

The program is motivated in part by the need to attract and retain highly qualified radiologists in times of ongoing global scarcity.

Dr. Farzana Rahman, CEO of Hexarad, said, “We believe that offering equity to our radiologists will be truly disruptive in the teleradiology market. It will help address radiologists’ top concerns and make our reporters feel like they really feel valued and rewarded for their expertise. “

Enovacom launches a solution that centralizes patient data in a single app

Orange Business Services’ health technology subsidiary Enovacom has announced the launch of its app, which centralizes and uses patient health data.

Enovacom Patient Link is available in France and will be rolled out in more countries next year. The interoperable solution can be used by healthcare providers to facilitate administrative formalities, manage treatment pathways and share patient data.

Laurent Frigara, Deputy CEO of Enovacom, said: “The aim is to have a positive impact on both the everyday life of medical staff and the health experience of patients, while leveraging data.”

Five new rare disease partners join the Healthinote platform

The Cognitant Group has added five rare disease charities to the bank of approved content partners for its health information platform, Healthinote.

The digital tool, which is integrated with the triaging and remote consulting company eConsult, can be used by more than 3,000 general practitioner practices in the UK.

Charities AKU Society, Niemann-Pick UK (NPUK), Pompe Support Network, the Cure & Action for Tay-Sachs (CATS) Foundation and the NCBRS Worldwide Foundation have joined the platform.

Lee Reavey, co-founder and executive director of the NCBRS Worldwide Foundation, said, “With fewer than 220 confirmed cases worldwide, even most health professionals have never heard of Nicolaides-Baraitser Syndrome. That is why we are proud to become a partner of Healthinote. “

Study Shows OptimiseRx May Improve Antipsychotics Prescribing

A study of the use of the FDB OptimiseRx drug optimization solution by NHS primary care physicians found that it could have clinical benefits and financial implications by reducing antipsychotic drugs for those at risk.

OptimiseRx, used by more than 4,000 primary care practices in England and Wales, sends messages when a prescription does not meet best practice guidelines.

As part of a study commissioned by the FDB, the Kent Surrey Sussex Academic Health Science Network (KSS AHSN) performed a health economic analysis of three reports in OptimiseRx related to the prescription of antipsychotics.

Analytical modeling over a five-year period predicts the benefits associated with the reports, including a lower incidence of diabetes and treatment costs, a reduction in the incidence of stroke, a reduction in outpatient and inpatient costs associated with tardive dyskinesia, and reduced prescribing costs.

Leave a Comment